NPPB and hydrops fetalis: This study randomized 5988 patients with NYHA class II–IV HF, EF > 40%, and NT-proBNP > 300 ng/L (or > 900 ng/L when in atrial fibrillation) to empagliflozin 10 mg once daily or placebo, in addition to usual therapy.